Vascular Biogenics Ltd. Cash and Cash Equivalents 2011-2026 | VBLT

Annual Cash and Cash Equivalents Vascular Biogenics Ltd.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.8 M	1.58 M	22 M	13.2 M	9.44 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
22 M	1.58 M	11.6 M

Quarterly Cash and Cash Equivalents Vascular Biogenics Ltd.

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.09 M	8.17 M	11.8 M	20.8 M	1.9 M	26.1 M	17.7 M	18.3 M	15.1 M	13.3 M	22 M	25.3 M	31.7 M	24.2 M	13.2 M	11.6 M	16.7 M	12.9 M	9.44 M	-	-	-	29.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
31.7 M	1.9 M	16.7 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	18 M	$ 4.5	0.45 %	$ 862 M	Canada
ADC Therapeutics SA ADCT	326 M	$ 3.83	1.32 %	$ 105 M	Schweiz
Agenus AGEN	3 M	$ 3.64	9.31 %	$ 108 M	USA
Agios Pharmaceuticals AGIO	89.1 M	$ 35.08	-0.36 %	$ 2.03 B	USA
Akebia Therapeutics AKBA	185 M	$ 1.39	0.36 %	$ 357 M	USA
Akari Therapeutics, Plc AKTX	2.6 M	$ 3.95	-11.63 %	$ 266 B	Britain
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Aldeyra Therapeutics ALDX	70 M	$ 1.57	-5.42 %	$ 94.3 M	USA
Aligos Therapeutics ALGS	18.3 M	$ 8.08	1.38 %	$ 79.9 M	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Alnylam Pharmaceuticals ALNY	1.66 B	$ 331.14	3.85 %	$ 43.4 B	USA
Altimmune ALT	43.8 M	$ 3.4	1.8 %	$ 300 M	USA
ALX Oncology Holdings ALXO	16.4 M	$ 1.99	0.81 %	$ 107 M	USA
Amgen AMGN	9.13 B	$ 344.03	-1.12 %	$ 185 B	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Amneal Pharmaceuticals AMRX	282 M	$ 12.27	-1.68 %	$ 3.85 B	USA
Anika Therapeutics ANIK	72.9 M	$ 14.99	1.28 %	$ 220 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
ANI Pharmaceuticals ANIP	145 M	$ 73.8	-0.55 %	$ 1.43 B	USA
Annexon ANNX	162 M	$ 5.56	1.0 %	$ 862 M	USA
Annovis Bio ANVS	19.5 M	$ 2.56	12.28 %	$ 52.6 M	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Aptorum Group Limited APM	3.5 M	$ 0.88	-5.16 %	$ 4.8 M	China
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aprea Therapeutics APRE	14.6 M	$ 0.7	-1.87 %	$ 4.58 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.12	-0.24 %	$ 441 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Arcturus Therapeutics Holdings ARCT	231 M	$ 8.14	1.31 %	$ 223 M	Israel
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Ardelyx ARDX	68 M	$ 5.99	0.84 %	$ 1.44 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
argenx SE ARGX	3.49 B	$ 749.99	0.48 %	$ 25 B	Niderland
Arcutis Biotherapeutics ARQT	42.9 M	$ 24.06	1.82 %	$ 3.06 B	USA
Arvinas ARVN	143 M	$ 10.87	0.14 %	$ 771 M	USA
Arrowhead Pharmaceuticals ARWR	227 M	$ 60.28	-1.23 %	$ 8.06 B	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Assembly Biosciences ASMB	58.4 M	$ 29.51	1.72 %	$ 331 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	3.22 M	-	10.36 %	$ 9.8 M	USA
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.62	1.82 %	$ 8.71 B	Australia